Related Experiment Videos

The surgical management of medullary thyroid carcinoma

Annals of Surgery
|January 1, 1983
PubMed

Insights

Medullary thyroid carcinoma presents in multiple endocrine neoplasia (MEN2a, MEN2b) and sporadic cases, with varying prognoses. Early diagnosis through calcitonin screening in relatives improves outcomes and reduces surgical extent.

Area of Science:

  • Endocrinology
  • Oncology
  • Surgical Pathology

Background:

  • Medullary thyroid carcinoma (MTC) has distinct patient groups: multiple endocrine neoplasia types 2a and 2b (MEN2a, MEN2b), and sporadic cases.
  • Prognosis varies significantly, being best in MEN2a and worst in MEN2b.
  • Multicentric disease is prevalent in MEN groups (90%) compared to sporadic cases (20%).

Purpose of the Study:

  • To outline the clinical presentation and management of medullary thyroid carcinoma.
  • To emphasize the importance of screening and early diagnosis for improved patient outcomes.
  • To define optimal surgical approaches for MTC.

Main Methods:

  • Review of patient groups with medullary thyroid carcinoma.
  • Analysis of prognostic factors and disease presentation.
  • Evaluation of surgical intervention effectiveness and screening protocols.

Main Results:

  • Prognosis is most favorable in MEN2a and least favorable in MEN2b.
  • Multicentricity is common in MEN-associated MTC.
  • Total thyroidectomy with central compartment node dissection is the minimum recommended surgery; extensive neck dissection offers no added benefit.

Conclusions:

  • Screening of primary relatives via plasma calcitonin measurement is crucial for early MTC diagnosis.
  • Early diagnosis facilitates less extensive surgery and increases the likelihood of a disease-free state.
  • Understanding patient groups and screening protocols optimizes medullary thyroid carcinoma management.

Related Concept Videos